Subunit Vaccines Using TLR Triagonist Combination Adjuvants Provide Protection Against Coxiella burnetii While Minimizing Reactogenic Responses
Q fever is caused by the obligate intracellular bacterium, Coxiella burnetii, a designated potential agent of bioterrorism because of its route of transmission, resistance to disinfectants, and low infectious dose. The only vaccine licensed for human use is Q-VAX® (Seqirus, licensed in Australia), a...
Main Authors: | Alycia P. Fratzke, Sharon Jan, Jiin Felgner, Li Liang, Rie Nakajima, Algis Jasinskas, Saikat Manna, Fnu N. Nihesh, Sampa Maiti, Tyler J. Albin, Aaron P. Esser-Kahn, D. Huw Davies, James E. Samuel, Philip L. Felgner, Anthony E. Gregory |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.653092/full |
Similar Items
-
Multivalent vaccines demonstrate immunogenicity and protect against Coxiella burnetii aerosol challenge
by: Sharon Jan, et al.
Published: (2023-07-01) -
Coxiella burnetii outbreak, Northern Italy 2021
by: Annacarla Chiesa, et al.
Published: (2023-12-01) -
Editorial: Non-reactogenic vaccines against Q-fever
by: Anthony E. Gregory, et al.
Published: (2023-05-01) -
An unexpected case of Coxiella burnetii endocarditis
by: Stefan Cristian Malciolu, et al.
Published: (2023-03-01) -
Performance Evaluation and Validation of Air Samplers To Detect Aerosolized Coxiella burnetii
by: A. M. Hasanthi Abeykoon, et al.
Published: (2022-10-01)